How patent gridlock is blocking the development of lifesaving drugs by Michael Heller, Forbes
…
Nicholas Naclerio, who used to head the BioChip Division at Motorola , told Scientific American, “If we want to make a medical diagnostic with 40 genes on it, and 20 companies hold patents on those genes, we may have a big problem.”
…
And it’s not just drugs we’re losing. Today anything high tech–banking, semiconductors, software, telecom–demands the assembly of innumerable patents. Innovation has moved on, but we’re stuck with old-style ownership that’s easy to fragment and hard to put together. This debacle’s only upside is that assembling fragmented property is one of the great entrepreneurial and political opportunities of our era.
This is a critical problem I have written about before. The broken patent system is a serious problem that needs to be fixed.
Related: The Effects of Patenting on Science – Patent Policy Harming USA, and the world – Patenting Life is a Bad Idea – The Differences Between Culture and Code – Innovation and Creative Commons – The Value of the Public Domain – The Patent System Needs to be Significantly Improved – Are Software Patents Evil?




